| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |